Atlas Trials

A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria

Clinical trial NCT00257140 · COMPLETED

Trial details

NCT number
NCT00257140
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
BronchitisBronchitis, Chronic
Start date
1931-06-01
Enrollment
367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.